Abstract
This report looks at how the minor ailment remedies market has evolved since Mintel last looked at it in 2006. Over the last two years, market growth has remained strong, propelled by consumers' increasing tendency to self-diagnose and the rising accessibility of products. Grocery multiples and the internet are stealing market share from chemists. Manufacturer brands are facing strong competition from retailer own-label products.
Main report themes
- How much does the market benefit from consumers stocking minor ailment remedies ‘just in case' , or is the market needs-driven?
- The extent to which convenience and speed of response drives new product development.
- Are consumers moving towards prevention versus treatment?
- Does the future lie in more use of natural ingredients and beauty benefits?
Table of Contents
- Issues in the Market
- Main report themes
- Definition
- Market in Brief
- Healthy growth
- Looking after number one
- Creating interest
- Looking forward
- Internal Market Environment
- Key points
- Reduced suffering
- Figure 1: Selected minor ailments suffered from in the last 12 months,
UK, 2003-07
- Got a bad back?
- Counting sheep
- Handling hayfever
- A healthy outlook
- Figure 2: Attitudes towards health, 2003-07
- Men offer potential, women keenest on complementary medicines
- Self-care
- Online help
- Convenience
- Own-label encroachment
- Licensing changes
- Figure 3: Licensing changes in minor ailment remedies, 2007-08
- Broader Market Environment
- Key points
- Paying the price
- Figure 4: Adult population trends, by socio-economic group, 2003-13
- A greying population
- Figure 5: Structure of the UK population, by age and gender, 2003-13
- Standing alone
- Figure 6: Trends in household size, UK, 2003-13
- Chemists get super
- Competitive Context
- Key points
- Treatments
- Complementary medicines
- Figure 7: UK retail value sales of complementary medicines, 2003-07
- Thanks, doc
- Preventative measures
- Vitamins, minerals and supplements
- Figure 8: Vitamin intake, 2003-07
- In context
- Figure 9: Market value of OTC pharmaceuticals, 2003-07
- Strengths and Weaknesses in the Market
- Strengths
- Weaknesses
- Market Value and Forecast
- Key points
- Springing into action
- Figure 11: UK retail value sales of minor ailment remedies, 2003-13
- Forecast
- Factors used in the forecast
- Segment Performance
- Key points
- Allergy remedies -- something in the air
- Figure 12: UK retail value sales of minor ailment remedies, by type,
2005-08
- Thrush and anti-fungals -- good growth
- Topical pain/anti-rheumatic remedies -- feeling the pain
- Emollients and anti-pruritics -- return to growth
- Eyecare
- Sleeping aids -- benefiting from hectic lifestyles
- Mouth ulcers -- being run down is running up sales
- Cold sore remedies -- a soaring market
- Head-lice treatments -- star performers
- Haemorrhoid remedies -- looking for inspiration
- Best foot forward
- Scalp treatments -- a static market
- Cystitis remedies
- Travel sickness remedies -- staying steady
- Companies and Products
- Key points
- Leading manufacturers -- brand map
- Figure 13: Brand map of the top eight minor ailment remedy
manufacturers, 2008
- Own-label suppliers
- Figure 14: Suppliers of own-label minor ailment remedies, 2008
- Leading suppliers by sector
- Hayfever and allergy remedies
- Figure 15: Brands' retail value shares in hayfever remedies, 2003-07
- Piriton and Piriteze (GSK)
- Beconase and Flixonase (GSK)
- Benadryl (Johnson & Johnson)
- Clarityn (Schering-Plough)
- Other brands
- Emollients and anti-pruritics
- Figure 16: Key emollient and anti-pruritic brands, 2008
- E45 (Reckitt Benckiser)
- Other brands
- Topical pain/anti-rheumatics
- Figure 17: Key topical pain/anti-rheumatic brands, 2008
- Ibuleve (DDD)
- 4Head (DDD)
- Nurofen (Reckitt Benckiser)
- Voltarol (Novartis)
- Eyecare products
- Optrex (Reckitt Benckiser)
- Other brands
- Mouth pain/ulcer remedies
- Bonjela (Reckitt Benckiser)
- Corsodyl (GSK)
- Other brands
- Cold sores
- Zovirax (GSK)
- Compeed (Johnson & Johnson)
- Haemorrhoid remedies
- Germoloids (Bayer)
- Anusol (Johnson & Johnson)
- Head lice/infestations
- Full Marks (SSL)
- Hedrin (Thornton & Ross)
- Thrush remedies/anti-fungals
- Figure 18: Key thrush/anti-fungal brands, 2008
- Canesten (Bayer)
- Lamisil (Novartis)
- Daktarin (Johnson & Johnson)
- Footcare
- Scholl (SSL)
- Bazuka (DDD)
- Other brands
- Sleeping aids
- Nytol (GSK)
- Scalp treatments
- Regaine (Johnson & Johnson)
- Nizoral (Johnson & Johnson)
- Travel sickness
- Kwells (Bayer)
- Stugeron 15 (Johnson & Johnson)
- Scopoderm (Novartis)
- Cystitis remedies
- Cystopurin (Bayer)
- Earcare
- Otex (DDD)
- Brand Communication and Promotion
- Key points
- Speculate to accumulate
- Figure 19: Main monitored media advertising expenditure on selected
minor ailment remedies, by major manufacturers, 2003-07
- Educate and differentiate
- Below-the-line activity
- Channels to Market
- Key points
- Multiples multiply
- Figure 20: UK retail value sales of minor ailment remedies, by outlet
type, 2006 and 2008
- Remedies to your door
- The Consumer -- Supplies and Usage
- Key points
- Stocks of minor ailment remedies
- Figure 21: Minor ailment remedies kept in stock at home, February 2008
- What do consumers keep in stock?
- Out of stock
- They' re at that age when ...
- Family medicine cabinets are well stocked
- Unprepared
- Women are the carers
- Money tied up on the shelf
- Who uses what?
- Figure 22: Minor ailment remedies bought or used occasionally in the
past, February 2008
- Anticipate the need
- Remedy kits
- Engaging younger consumers
- Am I bothered?
- The Consumer -- Response to Symptoms
- Key points
- Response to suffering from a minor ailment
- Figure 23: Consumer response to a minor ailment, February 2008
- Not afraid to ask
- Not so natural
- Delayed reacters provide potential
- Youthful enthusiasm
- Letting nature take its course
- Time heals?
- Pot luck with a pain-killer
- Targeting the problem
- No consultation necessary
- Professional opinion key for older patients
- Pharmacist first
- Appendix
- Advertising data
- Abbreviations
- Appendix: Internal Market Environment
- Figure 26: Attitudes towards health, by gender, 2007
- Appendix: The Consumer -- Supplies and Usage
- Figure 27: OTC minor ailment remedies, stock kept at home, by
demographic sub-group, February 2008
- Figure 28: OTC minor ailment remedies, stock kept at home, by
demographic sub-group, February 2008
- Figure 29: OTC minor ailment remedies, bought/used occasionally, by
demographic sub-group, February 2008
- Figure 30: OTC minor ailment remedies, bought/used occasionally, by
demographic sub-group, February 2008
- Appendix: The Consumer -- Response to Symptoms
- Figure 31: Consumer response to suffering from a minor ailment, by
demographic sub-group, February 2008
- Figure 32: Consumer response to suffering from a minor ailment, by
demographic sub-group, February 2008
|
相關報告
|
